Passerini Laura, Santoni de Sio Francesca Romana, Roncarolo Maria Grazia, Bacchetta Rosa
1Division of Regenerative Medicine, Stem Cells and Gene Therapy, San Raffaele Telethon Institute for Gene Therapy, San Raffaele Scientific Institute, Milan, Italy.
Int Rev Immunol. 2014 Mar;33(2):129-45. doi: 10.3109/08830185.2013.863303. Epub 2013 Dec 19.
Ten years ago Forkhead box P3 (FOXP3) was discovered as master gene driving CD4(+)CD25(+) T cell regulatory (Treg) function. Since then, several layers of complexity have emerged in the regulation of its expression and function, which is not only exerted in Treg cells. While the mechanisms leading to the highly selective expression of FOXP3 in thymus-derived Treg cells still remain to be elucidated, we review here the current knowledge on the role of FOXP3 in the development of Treg cells and the direct and indirect consequences of FOXP3 mutations on multiple arms of the immune response. Finally, we summarize the newly acquired knowledge on the epigenetic regulation of FOXP3, still largely undefined in human cells.
十年前,叉头框蛋白P3(FOXP3)被发现是驱动CD4(+)CD25(+) T细胞调节(Treg)功能的主控基因。从那时起,其表达和功能的调控出现了多层次的复杂性,这种调控不仅作用于Treg细胞。虽然导致FOXP3在胸腺来源的Treg细胞中高度选择性表达的机制仍有待阐明,但我们在此回顾关于FOXP3在Treg细胞发育中的作用以及FOXP3突变对免疫反应多个环节的直接和间接影响的现有知识。最后,我们总结了关于FOXP3表观遗传调控的新获得的知识,这在人类细胞中仍很大程度上未明确。